CALCITRIOL-GA calcitriol 0.25 microgram capsule blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

calcitriol, Quantity: 0.25 microgram

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

Calcitriol

forme pharmaceutique:

Capsule, soft

Composition:

Excipient Ingredients: glycerol; sorbitol solution (70 per cent) (non-crystallising); butylated hydroxyanisole; iron oxide yellow; fractionated coconut oil; butylated hydroxytoluene; Gelatin; iron oxide red; purified water

Mode d'administration:

Oral

Unités en paquet:

100 capsules

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Calcitriol-GA is indicated for the treatment of established osteoporosis diagnosed by objective measuring techniques, such as densitometry, or by radiographic evidence of atraumatic fracture. Calcitriol-GA is also indicated for the prevention of corticosteroid-induced osteoporosis in patients commencing oral steroid therapy in a dose and regimen expected to result in a significant bone loss. Calcitriol-GA is indicated in the treatment of hypocalcemia in patients with uremic osteodystrophy, hypoparathyroidism and in hypophosphataemic rickets.

Descriptif du produit:

Visual Identification: Red coloured, oval, soft-gelatin capsules containing a clear, oily liquid.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-08-21